Press Releases

The Trustees of the Tate & Lyle PLC Employee Benefit Trust (Number 1) (the "EBT") notified the Company on 16 June 2003 that on 16 June 2003 it had bought 765,000 Tate & Lyle PLC ordinary shares at an average price of 334.61 pence per share. By virtue of their interests in the Tate & Lyle 2000...

Tate & Lyle PLC (“Tate & Lyle”) announces that it has completed the sale of Tate & Lyle Canada Ltd (“Redpath”) to American Sugar Refining, Inc. The signing of a conditional agreement for this disposal was announced on 14 February 2007. The effective date for this transaction is 22 April 2007. The...

This Trading Statement covers the period from 1 April 2015 to 30 June 2015, which is the first quarter of the financial year.

Press release and connection details for audio webcast available for the Half Year Results for the six months to 30 September 2016.

In accordance with our usual practice, Tate & Lyle PLC issues the following update for the year ended 31 March 2014 ahead of the announcement of full year results on 29 May 2014. In line with the guidance issued in our interim management statement on 13 February 2014, we continue to expect Group...

Tate & Lyle PLC (Tate & Lyle) announces the exit from the substantial part of its European Bulk Ingredients business and the re-structuring of its SPLENDA® Sucralose business to further focus on and strengthen Speciality Food Ingredients.

Tate & Lyle issues the following routine trading update. Group profit before tax in the third quarter of the year to 31 March 2003 has been in line with our expectations. Since the end of September 2002 net debt, assisted by proceeds from the sale of non-core assets, has continued to reduce. In the...

At the Annual General Meeting of Tate & Lyle PLC in London today, Sir David Lees, Chairman, made the following statement on current trading: We are at an early stage in our current financial year but I am pleased to report that trading in the quarter ended June 2002 is above our internal...

The following information is provided in compliance with paragraph 16.4 of the FSA Listing Rules in respect of the appointments of Dr David Fish and Mr Evert Henkes as Non-Executive Directors of Tate & Lyle PLC on 1 December 2003 (as announced on 5 November 2003). Dr David Fish i) Dr Fish is...

Tate & Lyle PLC (“Tate & Lyle”) announces the sale of its international sugar trading operations to Bunge Limited (“Bunge”) for an undisclosed amount. The disposal, which is conditional on anti-trust approval in a small number of countries, represents another step in delivering on Tate & Lyle’s...